The legal staff at Clark+Elbing consists of a nucleus of attorneys with advanced scientific degrees supported by a team of patent agents and technology specialists, each of whom holds a PhD in a scientific discipline.
We have unparalleled expertise in the biological and biochemical sciences, with professionals holding doctorates in such fields as chemistry, genetics, neuroscience, cell biology, developmental biology, molecular biology, neurobiology, and pharmacology.
Please click on a name above to view that individual's biography.
JD magna cum laude, Suffolk University Law School
PhD Genetics, Harvard University
BS cum laude Microbiology, University of Massachusetts Amherst
Registered to practice before the U.S. Patent and Trademark Office
Admitted to the bar in Massachusetts, U.S. Federal courts, and the Court of Appeals for the Federal Circuit
Karen Elbing is a partner of Clark+Elbing, which she co-founded in 1996 with a group from Fish & Richardson, where she had been since 1990. Karen serves as counsel to clients in the United States, Europe, Canada, and Japan. Her clients include companies of all sizes (start-up, mid-size, and Fortune 500), non-profit research and educational institutions, and venture capital firms.
Karen has extensive experience helping clients to identify and protect their intellectual property; to build their patent portfolios through strategic patent prosecution and patent in-licensing; and to analyze competitors' intellectual property. She serves as counsel to venture capital firms making investments in the biotechnology and pharmaceutical sectors, and is well-versed in patent portfolio management and the interplay of intellectual property with business and regulatory matters.
Karen's litigation experience includes serving as second chair on behalf of Genentech in patent infringement litigation before the U.S. International Trade Commission (human growth hormone) and having participated in the Federal Circuit appeal of New Medical Center Hospitals v. Peprotech (human IL-1beta). She regularly provides opinions on patent infringement and validity.
As a scientist, Karen studied molecular biology, and she is the first author of research articles published in Cell and the Journal of Bacteriology. She is also an original and ongoing contributor to Current Protocols in Molecular Biology. Her practice emphasizes inventions in the field of molecular biology, including transgenic animals, recombinant nucleic acid and protein products, and drug development technologies. Other practice areas include biochemistry, immunology, and pharmaceutical chemistry.
Select Awards & Honors
Member, Phi Beta Kappa
Articles Editor, Suffolk University Law Review
Named "Most Outstanding Woman Law Student" by the National Organization of Women Lawyers
Recognized in Boston Magazine as a Massachusetts Super Lawyer, 2005-2007, and 2010
Recognized as a New England Super Lawyer, 2007